ACR Convergence 2020

RSMU researchers attended ACR Convergence 2020 – the American College of Rheumatology’s first all-virtual annual meeting.

This year’s meeting was one for the record books, with over 16,000 attendees from 111 countries. The participation of the members of RSMU Department of Hospital Therapy made the meeting an enriching and valuable experience.

It should be mentioned that the report of our colleagues “Olokizumab Improves Patient Reported Outcomes in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate: Results from the Double-Blind, Randomized Controlled Phase III Study”  was included to the approved abstract list and can be found  here: